Shu, Yilai

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology

RNA Interference and Gene DeliveryCRISPR and Genetic Engineering

Cited by 1,460

Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

Gao, X., Tao, Y., Lamas, V., Huang, M., Yeh, W.-H., Pan, B., Hu, Y.-J., Hu, J. H., Thompson, D. B., Shu, Y., et al. (2018) · Nature

Hearing, Cochlea, Tinnitus, GeneticsCRISPR and Genetic Engineering

Cited by 536

Cognitive Decline, Dementia, Alzheimer’s Disease and Presbycusis: Examination of the Possible Molecular Mechanism

Shen, Y., Ye, B., Chen, P., Wang, Q., Fan, C., Shu, Y., & Xiang, M. (2018) · Frontiers in Neuroscience

Alzheimer's disease research and treatmentsHearing, Cochlea, Tinnitus, Genetics

Cited by 105

Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor

Xiao, Q., Xu, Z., Xue, Y., Xu, C., Han, L., Liu, Y., Wang, F., Zhang, R., Han, S., Wang, X., et al. (2022) · Science Translational Medicine

CRISPR and Genetic EngineeringHearing, Cochlea, Tinnitus, Genetics

Cited by 95

PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest

Yuan, Y., Wang, C., Zhuang, X., Lin, S., Luo, M., Deng, W., Zhou, J., Liu, L., Mao, L., Peng, W., et al. (2022) · Nature Communications

Bioinformatics and Genomic NetworksFerroptosis and cancer prognosis

Cited by 16